Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 7 | 2019 | 283 | 2.110 |
Why?
|
| Emergency Service, Hospital | 15 | 2018 | 429 | 1.720 |
Why?
|
| Acute Coronary Syndrome | 11 | 2017 | 175 | 1.410 |
Why?
|
| Myocardial Infarction | 9 | 2018 | 412 | 1.100 |
Why?
|
| Chest Pain | 9 | 2018 | 175 | 0.990 |
Why?
|
| Body Surface Potential Mapping | 4 | 2012 | 12 | 0.870 |
Why?
|
| Emergency Medicine | 3 | 2016 | 117 | 0.700 |
Why?
|
| Schools, Medical | 1 | 2018 | 42 | 0.640 |
Why?
|
| Liability, Legal | 1 | 2018 | 28 | 0.640 |
Why?
|
| Curriculum | 2 | 2018 | 196 | 0.610 |
Why?
|
| Career Choice | 1 | 2016 | 40 | 0.570 |
Why?
|
| Telemedicine | 1 | 2016 | 73 | 0.530 |
Why?
|
| Decision Support Techniques | 4 | 2017 | 104 | 0.520 |
Why?
|
| Subcutaneous Emphysema | 1 | 2014 | 3 | 0.520 |
Why?
|
| Lower Extremity | 1 | 2014 | 93 | 0.470 |
Why?
|
| Critical Pathways | 4 | 2018 | 49 | 0.460 |
Why?
|
| Laparoscopy | 1 | 2014 | 169 | 0.440 |
Why?
|
| Professional Competence | 1 | 2012 | 16 | 0.440 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 34 | 0.430 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 46 | 0.420 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 83 | 0.420 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 82 | 0.400 |
Why?
|
| Risk Assessment | 4 | 2016 | 1300 | 0.390 |
Why?
|
| Humans | 27 | 2019 | 28998 | 0.370 |
Why?
|
| Emergency Treatment | 1 | 2010 | 42 | 0.370 |
Why?
|
| Postoperative Complications | 1 | 2014 | 670 | 0.360 |
Why?
|
| Algorithms | 1 | 2012 | 461 | 0.350 |
Why?
|
| Electrocardiography | 8 | 2016 | 562 | 0.340 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2008 | 32 | 0.320 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 863 | 0.320 |
Why?
|
| Clinical Competence | 2 | 2018 | 307 | 0.270 |
Why?
|
| Cardiology Service, Hospital | 2 | 2015 | 22 | 0.240 |
Why?
|
| Troponin | 6 | 2016 | 79 | 0.240 |
Why?
|
| Female | 18 | 2018 | 18112 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 1216 | 0.220 |
Why?
|
| Aged | 12 | 2018 | 9461 | 0.220 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 784 | 0.200 |
Why?
|
| Male | 18 | 2018 | 17767 | 0.200 |
Why?
|
| Middle Aged | 15 | 2018 | 10805 | 0.200 |
Why?
|
| Medical Staff, Hospital | 2 | 2011 | 18 | 0.190 |
Why?
|
| Patient Admission | 2 | 2011 | 53 | 0.190 |
Why?
|
| United States | 5 | 2016 | 3604 | 0.180 |
Why?
|
| Personnel Selection | 1 | 2019 | 14 | 0.180 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 531 | 0.170 |
Why?
|
| School Admission Criteria | 1 | 2019 | 11 | 0.170 |
Why?
|
| Adult | 11 | 2018 | 8391 | 0.170 |
Why?
|
| Myocardial Revascularization | 2 | 2015 | 37 | 0.170 |
Why?
|
| Coronary Angiography | 3 | 2018 | 136 | 0.160 |
Why?
|
| Exercise Test | 3 | 2016 | 194 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 724 | 0.150 |
Why?
|
| Troponin C | 1 | 2017 | 9 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 493 | 0.140 |
Why?
|
| Patient Discharge | 2 | 2015 | 168 | 0.140 |
Why?
|
| Perception | 1 | 2016 | 92 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 87 | 0.140 |
Why?
|
| Death | 1 | 2015 | 41 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2017 | 1674 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2016 | 108 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2016 | 331 | 0.130 |
Why?
|
| Decision Making | 1 | 2016 | 180 | 0.120 |
Why?
|
| Postural Balance | 1 | 2016 | 160 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2013 | 19 | 0.120 |
Why?
|
| Pesticides | 1 | 2016 | 189 | 0.120 |
Why?
|
| North Carolina | 5 | 2016 | 1422 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2016 | 2010 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 54 | 0.110 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.110 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.110 |
Why?
|
| Transients and Migrants | 1 | 2016 | 281 | 0.110 |
Why?
|
| Observer Variation | 1 | 2012 | 96 | 0.110 |
Why?
|
| Arteriovenous Malformations | 1 | 2012 | 7 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2012 | 165 | 0.110 |
Why?
|
| Cataract Extraction | 1 | 2012 | 8 | 0.110 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 9 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2016 | 3100 | 0.110 |
Why?
|
| Carotid Artery, Common | 1 | 2012 | 37 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2011 | 36 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2011 | 61 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 462 | 0.100 |
Why?
|
| Inpatients | 1 | 2011 | 64 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2011 | 97 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 116 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 142 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 161 | 0.090 |
Why?
|
| Hispanic Americans | 1 | 2016 | 904 | 0.090 |
Why?
|
| Teaching | 1 | 2009 | 55 | 0.090 |
Why?
|
| Physicians | 1 | 2011 | 134 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2010 | 120 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 3712 | 0.080 |
Why?
|
| Atherectomy | 1 | 2008 | 4 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.080 |
Why?
|
| Length of Stay | 3 | 2015 | 291 | 0.080 |
Why?
|
| Risk Factors | 4 | 2017 | 3509 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2007 | 61 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2008 | 90 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2008 | 110 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 373 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 298 | 0.070 |
Why?
|
| Cost Savings | 2 | 2016 | 32 | 0.060 |
Why?
|
| Time Factors | 3 | 2015 | 1997 | 0.060 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 88 | 0.060 |
Why?
|
| Linear Models | 2 | 2011 | 425 | 0.050 |
Why?
|
| Prognosis | 2 | 2015 | 1362 | 0.050 |
Why?
|
| Correspondence as Topic | 1 | 2019 | 3 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2105 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2019 | 111 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 871 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2016 | 32 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2016 | 95 | 0.040 |
Why?
|
| Cardiology | 1 | 2016 | 71 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 113 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 22 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 795 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 855 | 0.030 |
Why?
|
| Observation | 1 | 2013 | 23 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1105 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1105 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2012 | 18 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2013 | 105 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 23 | 0.030 |
Why?
|
| Face | 1 | 2012 | 25 | 0.030 |
Why?
|
| Models, Economic | 1 | 2011 | 18 | 0.030 |
Why?
|
| Faculty | 1 | 2011 | 15 | 0.030 |
Why?
|
| Dobutamine | 1 | 2011 | 43 | 0.030 |
Why?
|
| Drug Costs | 1 | 2011 | 42 | 0.030 |
Why?
|
| Adenosine | 1 | 2011 | 41 | 0.030 |
Why?
|
| Echocardiography | 1 | 2011 | 140 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 706 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 128 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 170 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 239 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 161 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 156 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 42 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 440 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 157 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 501 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 417 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 1353 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3094 | 0.010 |
Why?
|